HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Hybrid Imaging

Hybrid Imaging is a revolutionary approach in medical diagnostics that involves the integration of two or more imaging modalities to provide comprehensive and synergistic information. The most widely recognized form of hybrid imaging is positron emission tomography-computed tomography (PET-CT), where functional metabolic data from PET scans are combined with detailed anatomical information obtained from CT scans. This powerful fusion enables healthcare professionals to correlate metabolic activity with precise anatomical localization, significantly enhancing the accuracy of diagnosis and staging in various medical conditions, particularly cancer. The integration of PET-CT has become a cornerstone in oncology, guiding treatment decisions, monitoring therapy response, and aiding in the detection of recurrent disease. Another significant example of hybrid imaging is single-photon emission computed tomography-computed tomography (SPECT-CT), which combines nuclear medicine's functional insights with CT's anatomical details. SPECT-CT is commonly employed in bone imaging, cardiac assessments, and specific oncological studies, offering a more comprehensive evaluation compared to standalone modalities.

Recent advancements have also led to the development of hybrid systems that integrate PET with magnetic resonance imaging (MRI), combining the strengths of PET's metabolic imaging with MRI's superior soft tissue contrast. This PET-MRI fusion is particularly valuable in neuroimaging, musculoskeletal evaluations, and oncological investigations, demonstrating the versatility and expanding applications of hybrid imaging in diverse clinical scenarios. The continued evolution of hybrid imaging technologies holds promise for further advancements in diagnostic precision and personalized medicine. As researchers explore novel combinations and refine existing hybrid imaging modalities, the field is witnessing improvements in spatial resolution, sensitivity, and the ability to capture dynamic processes within the body. The integration of hybrid imaging into routine clinical practice represents a significant step forward in diagnostic capabilities, enabling healthcare professionals to glean a more comprehensive understanding of diseases and tailor interventions with increased accuracy and efficacy.

Committee Members
Speaker at International Cancer Conference 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
ICC 2026 Speakers
Speaker at International Cancer Conference 2026 - Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Speaker at International Cancer Conference 2026 - Yi Chih Liang

Yi Chih Liang

National Sun Yat-Sen University, Taiwan
Speaker at International Cancer Conference 2026 - Omar Mohammad Alqaisi

Omar Mohammad Alqaisi

Al-Zaytoonah University, Jordan
Speaker at International Cancer Conference 2026 - Wu Junyao

Wu Junyao

Changhai Hospital, China

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp